Atlas Trials

A Study to Examine the Duration of Effect of PrEP-001 in Healthy Subjects Challenged With HRV-16

Clinical trial NCT03338556 · COMPLETED

Trial details

NCT number
NCT03338556
Sponsor
Prep Biopharm Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Viral Upper Respiratory Tract Infection
Start date
2016-04-06
Primary completion
2016-09-30
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.